We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Division of Cell and Molecular Biology studies the complex interplay of genes, proteins and biological processes that drive the development and growth of cancers. Understanding the many different ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

The ICR and The Royal Marsden have teamed up with PureGym to encourage men with advanced prostate cancer to be more active. The initiative will see PureGym offer a free one-year gym membership for ...

Soumak joined the Generations Study team in 2025 under the mentorship of Professor Garcia-Closas. He holds a bachelor’s degree in information technology and a postgraduate diploma in Business ...

The Centre for Children and Young People's Cancer (CCC) serves as the focal point of basic, translational and clinical paediatric oncology research at the ICR and The Royal Marsden. Our work involves ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Twenty years ago today, the International Genome Sequencing Consortium published the first detailed analysis of the human genome. The paper appeared online in Nature on 15 February 2001, followed by a ...

Whole-body MRI scans provide powerful insights into treatment effectiveness and long-term outcomes for patients with myeloma, an incurable but treatable blood cancer. Results from the iTIMM study led ...

Image of human melanoma tissue, with melanoma cells in green and purple extracellular matrix fibres arranged perpendicular at the border of the tumour. Credit Oscar Maiques Carlos Scientists have ...

A new type of blood test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research has shown. A team from The Institute of Cancer Research, ...